EDGAR Filing Documents for 0001193125-13-378663

Form S-8 - Securities to be offered to employees in employee benefit plans:

SEC Accession No. 0001193125-13-378663

Filing Date

2013-09-25

Accepted

2013-09-25 17:27:16

Documents

Effectiveness Date

2013-09-25

Document Format Files

Seq	Description	Document	Type	Size
1	S-8	d596972ds8.htm	S-8	57885
2	EX-4.1	d596972dex41.htm	EX-4.1	73932
3	EX-4.2	d596972dex42.htm	EX-4.2	74715
4	EX-4.3	d596972dex43.htm	EX-4.3	14306
5	EX-4.4	d596972dex44.htm	EX-4.4	147116
6	EX-4.5	d596972dex45.htm	EX-4.5	46001
7	EX-5.1	d596972dex51.htm	EX-5.1	4555
8	EX-23.1	d596972dex231.htm	EX-23.1	2451
	Complete submission text file	0001193125-13-378663.txt		421961

Mailing Address 225 PROMENADE DU CENTROPOLIS, SUITE 200 LAVAL A8 H7T 3B3

Business Address 225 PROMENADE DU CENTROPOLIS, SUITE 200 LAVAL A8 H7T 3B3 (450) 687-2262

Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)